- $5.26bn
- $4.14bn
- 32
- 25
- 62
- 33
Annual balance sheet for Nuvalent, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 10.3 | 288 | 472 | 720 | 1,118 |
| Prepaid Expenses | |||||
| Total Current Assets | 10.6 | 291 | 478 | 726 | 1,132 |
| Other Long Term Assets | |||||
| Total Assets | 10.6 | 294 | 482 | 732 | 1,142 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.38 | 8.79 | 19.5 | 31.8 | 54 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.62 | 8.79 | 19.5 | 31.8 | 72 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4.03 | 285 | 463 | 701 | 1,070 |
| Total Liabilities & Shareholders' Equity | 10.6 | 294 | 482 | 732 | 1,142 |
| Total Common Shares Outstanding |